Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer

Por Barroso-Sousa, Romualdo, Shapiro, Geoffrey I., Tolaney, Sara M.
Publicado no Breast Care (Basel) (2016)

A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

Por Tolaney, Sara M, Jeong, Joon, Guo, Hao, Brock, Jane, Morganstern, Daniel, Come, Steven E, Golshan, Mehra, Bellon, Jennifer, Winer, Eric P, Krop, Ian E
Publicado em 2014

Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase...

Por Burstein, Harold J., Cirrincione, Constance T., Barry, William T., Chew, Helen K., Tolaney, Sara M., Lake, Diana E., Ma, Cynthia, Blackwell, Kimberly L., Winer, Eric P., Hudis, Clifford A.
Publicado no J Clin Oncol (2014)

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Por Tolaney, Sara M., Nechushtan, Hovav, Ron, Ilan-Gil, Schöffski, Patrick, Awada, Ahmad, Yasenchak, Chris A., Laird, A. Douglas, O’Keeffe, Bridget, Shapiro, Geoffrey I., Winer, Eric P.
Publicado no Breast Cancer Res Treat (2016)

A Phase 1 trial of the PARP inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cance...

Por Liu, Joyce F., Tolaney, Sara M., Birrer, Michael, Fleming, Gini F., Buss, Mary K., Dahlberg, Suzanne E., Lee, Hang, Whalen, Christin, Tyburski, Karin, Winer, Eric, Ivy, Percy, Matulonis, Ursula A.
Publicado em 2013

Effect of the LIVESTRONG® at the YMCA exercise program on physical activity, fitness, quality of life and fatigue in cancer survivors

Por Irwin, Melinda L., Cartmel, Brenda, Harrigan, Maura, Li, Fangyong, Sanft, Tara, Shockro, Laura, O’Connor, Keelin, Campbell, Nancy, Tolaney, Sara M., Mayer, Erica L., Yung, Rachel, Freedman, Rachel A., Partridge, Ann H., Ligibel, Jennifer A.
Publicado no Cancer (2016)

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

Por Tolaney, Sara M., Tan, Sally, Guo, Hao, Barry, William, Van Allen, Eliezer, Wagle, Nikhil, Brock, Jane, Larrabee, Katherine, Paweletz, Cloud, Ivanova, Elena, Janne, Pasi, Overmoyer, Beth, Wright, John J., Shapiro, Geoffrey I., Winer, Eric P., Krop, Ian E.
Publicado no Invest New Drugs (2015)

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

Por Garber, Judy E., Halabi, Susan, Tolaney, Sara M., Kaplan, Ellen, Archer, Laura, Atkins, James N., Edge, Stephen, Shapiro, Charles L., Dressler, Lynn, Paskett, Electra M., Kimmick, Gretchen, Orcutt, James, Scalzo, Anthony, Winer, Eric, Levine, Ellis, Shahab, Nasir, Berliner, Nancy
Publicado em 2010

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Resp...

Por Sikov, William M., Berry, Donald A., Perou, Charles M., Singh, Baljit, Cirrincione, Constance T., Tolaney, Sara M., Kuzma, Charles S., Pluard, Timothy J., Somlo, George, Port, Elisa R., Golshan, Mehra, Bellon, Jennifer R., Collyar, Deborah, Hahn, Olwen M., Carey, Lisa A., Hudis, Clifford A., Winer, Eric P.
Publicado no J Clin Oncol (2015)

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

Por Tolaney, Sara M., Boucher, Yves, Duda, Dan G., Martin, John D., Seano, Giorgio, Ancukiewicz, Marek, Barry, William T., Goel, Shom, Lahdenrata, Johanna, Isakoff, Steven J., Yeh, Eren D., Jain, Saloni R., Golshan, Mehra, Brock, Jane, Snuderl, Matija, Winer, Eric P., Krop, Ian E., Jain, Rakesh K.
Publicado no Proc Natl Acad Sci U S A (2015)

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers With CDK4/6 Inhibitors

Por Goel, Shom, Wang, Qi, Watt, April C., Tolaney, Sara M., Dillon, Deborah A., Li, Wei, Ramm, Susanne, Palmer, Adam C., Yuzugullu, Haluk, Varadan, Vinay, Tuck, David, Harris, Lyndsay N., Wong, Kwok-Kin, Liu, X. Shirley, Sicinski, Piotr, Winer, Eric P., Krop, Ian E., Zhao, Jean J.
Publicado no Cancer Cell (2016)

Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients

Por Tolaney, Sara M., Ziehr, David R., Guo, Hao, Ng, Mei R., Barry, William T., Higgins, Michaela J., Isakoff, Steven J., Brock, Jane E., Ivanova, Elena V., Paweletz, Cloud P., Demeo, Michelle K., Ramaiya, Nikhil H., Overmoyer, Beth A., Jain, Rakesh K., Winer, Eric P., Duda, Dan G.
Publicado no Oncologist (2017)

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

Por Tolaney, Sara M., Barry, William T., Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew, Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth A., Partridge, Ann H., Guo, Hao, Hudis, Clifford A., Krop, Ian E., Burstein, Harold J., Winer, Eric P.
Publicado no N Engl J Med (2015)

Chemotherapy-Related Amenorrhea after Adjuvant Paclitaxel-Trastuzumab (APT Trial)

Por Ruddy, Kathryn J., Guo, Hao, Barry, William, Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew J., Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth A., Hudis, Clifford, Krop, Ian E., Burstein, Harold J., Winer, Eric P., Partridge, Ann H., Tolaney, Sara M.
Publicado no Breast Cancer Res Treat (2015)

Phase I safety, pharmacokinetic and pharmacodynamic study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with irinotecan in patients with a...

Por LoRusso, Patricia M., Li, Jing, Burger, Angelika, Heilbrun, Lance K., Sausville, Edward A., Boerner, Scott A., Smith, Daryn, Pilat, Mary Jo, Zhang, Jie, Tolaney, Sara M., Cleary, James M., Chen, Alice P., Rubinstein, Lawrence, Boerner, Julie L., Bowditch, Adam, Cai, Dongpo, Bell, Tracy, Wolanski, Andrew, Marrero, Allison M., Zhang, Yiping, Ji, Jiuping, Ferry-Galow, Katherine, Kinders, Robert J., Parchment, Ralph E., Shapiro, Geoffrey I.
Publicado no Clin Cancer Res (2016)